Currency In USD
| Previous Close | 20.72 |
| Open | 20.55 |
| Day High | 20.6 |
| Day Low | 18.61 |
| 52-Week High | 23.7 |
| 52-Week Low | 14.42 |
| Volume | 301,334 |
| Average Volume | 163,311 |
| Market Cap | 494.44M |
| PE | -18.69 |
| EPS | -1.03 |
| Moving Average 50 Days | 18.26 |
| Moving Average 200 Days | 17.58 |
| Change | -1.47 |
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
GlobeNewswire Inc.
Feb 12, 2026 9:05 PM GMT
WARSAW, Ind., Feb. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled
OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity
GlobeNewswire Inc.
Feb 03, 2026 12:05 PM GMT
OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and olderWARSAW, Ind., Feb. 03, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Co
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance
GlobeNewswire Inc.
Jan 12, 2026 12:05 PM GMT
Achieves all-time high full year 2025 Revenue of $236.1 million representing growth of 15% over prior yearInitiates guidance for record Adjusted EBITDA in 2026 WARSAW, Ind., Jan. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”